Status: Recruiting
CW-301 FIH Study of CAN016
A Phase I/II, Open-Label, Non-Randomized, Multi-Centre First-in-Human Study of CAN016 in Patients with Advanced Solid Tumors
Participants needed: 90
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Canwell Biotech LimitedUpdated: Jul 1, 2026Locations: 1
Eligibility criteria
Provide informed consent voluntarily [+9]
Patient has received any anticancer therapy (including chemotherapy, targeted th... [+5]